Tel. +49 203 / 555 858 -31 / 32 / 33 · Fax: +49 203 / 35 82 99
09.11.2023
Genekam to attend BIO CEO & Investor Conference
February 26-27, 2024 | New York
04.05.2023
Genekam registered with EUDAMED - A step towards meeting the latest IVDR requirements!
Genekam is to take part in European Community FP7 funded and approved research project called STRUCTGEL to develop nanomedicine applications in Stemcell field.